Insulet (PODD) News Today $275.81 +2.95 (+1.08%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Sax Wealth Advisors LLC Purchases 1,532 Shares of Insulet Co. (NASDAQ:PODD)Sax Wealth Advisors LLC grew its position in Insulet Co. (NASDAQ:PODD - Free Report) by 101.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 3,044 shares of the medical instruments supplier's stock after buying an additionalJanuary 19 at 4:49 AM | marketbeat.com6,742 Shares in Insulet Co. (NASDAQ:PODD) Bought by Avanza Fonder ABAvanza Fonder AB bought a new position in shares of Insulet Co. (NASDAQ:PODD - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 6,742 shares of the medical instruments supplier's stock, valued at approximately $1,7January 19 at 4:18 AM | marketbeat.comAssenagon Asset Management S.A. Increases Stock Position in Insulet Co. (NASDAQ:PODD)Assenagon Asset Management S.A. increased its holdings in Insulet Co. (NASDAQ:PODD - Free Report) by 8.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 104,392 shares of the medical instruments supplier's stock aftJanuary 17 at 4:09 AM | marketbeat.comCiti Sticks to Their Buy Rating for Insulet (PODD)January 16, 2025 | markets.businessinsider.comContravisory Investment Management Inc. Takes Position in Insulet Co. (NASDAQ:PODD)Contravisory Investment Management Inc. bought a new stake in Insulet Co. (NASDAQ:PODD - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 2,113 shares of the medical instruments supJanuary 16, 2025 | marketbeat.comUSA Financial Formulas Makes New Investment in Insulet Co. (NASDAQ:PODD)USA Financial Formulas acquired a new stake in Insulet Co. (NASDAQ:PODD - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 4,725 shares of the medical instruments supplier's stock, valuedJanuary 16, 2025 | marketbeat.comInsulet launches Omnipod 5 in five more countries in EuropeJanuary 14, 2025 | markets.businessinsider.comInsulet Co. (NASDAQ:PODD) Stake Lifted by Ayrshire Capital Management LLCAyrshire Capital Management LLC increased its position in Insulet Co. (NASDAQ:PODD - Free Report) by 34.6% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 22,988 shares of the medical instruments supplieJanuary 14, 2025 | marketbeat.comInsulet Omnipod 5 insulin system available in five more European countriesJanuary 13, 2025 | seekingalpha.comInsulet Corp Expands Omnipod 5 Availability Across EuropeJanuary 13, 2025 | gurufocus.comInsulet Launches Revolutionary Omnipod® 5 in Five More Countries in EuropeJanuary 13, 2025 | finance.yahoo.comInsulet Co. (NASDAQ:PODD) Receives Average Recommendation of "Moderate Buy" from AnalystsShares of Insulet Co. (NASDAQ:PODD - Get Free Report) have received a consensus rating of "Moderate Buy" from the sixteen analysts that are currently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buyJanuary 13, 2025 | marketbeat.comInsulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025January 10, 2025 | gurufocus.comInsulet Corp (PODD) Announces Upcoming Financial Results Release for Q4 and Full Year 2024January 10, 2025 | gurufocus.comInsulet to Announce Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025January 10, 2025 | businesswire.comInsulet Corp. stock underperforms Wednesday when compared to competitors despite daily gainsJanuary 9, 2025 | marketwatch.comInsulet price target raised to $315 from $305 at BernsteinJanuary 9, 2025 | msn.comBank of America Securities Keeps Their Buy Rating on Insulet (PODD)January 7, 2025 | markets.businessinsider.comWhat Does Insulet Corporation's (NASDAQ:PODD) Share Price Indicate?January 7, 2025 | finance.yahoo.comHere are J. P. Morgan’s top MedTech picks for 2025January 4, 2025 | msn.comInsulet price target raised to $324 from $264 at TD CowenJanuary 3, 2025 | markets.businessinsider.comInsulet (NASDAQ:PODD) Price Target Raised to $324.00TD Cowen increased their price objective on Insulet from $264.00 to $324.00 and gave the stock a "buy" rating in a report on Friday.January 3, 2025 | marketbeat.comTD Cowen Reaffirms Their Buy Rating on Insulet (PODD)January 3, 2025 | markets.businessinsider.comInsulet Corp. stock underperforms Tuesday when compared to competitorsJanuary 1, 2025 | marketwatch.comInsulet price target raised to $300 from $270 at BTIGDecember 30, 2024 | markets.businessinsider.comBTIG Sticks to Their Buy Rating for Insulet (PODD)December 30, 2024 | markets.businessinsider.comHeavy Interest in Insulet’s Insulin Delivery DeviceDecember 28, 2024 | finance.yahoo.comIs Insulet Stock Outperforming the Dow?December 27, 2024 | msn.comInsulet Corp. stock outperforms competitors on strong trading dayDecember 27, 2024 | marketwatch.comPrincipal Financial Group Inc. Acquires 3,355 Shares of Insulet Co. (NASDAQ:PODD)Principal Financial Group Inc. grew its stake in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 4.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 86,210 shares of the medical instruments supplier'sDecember 27, 2024 | marketbeat.comInsulet Corp. stock outperforms competitors despite losses on the dayDecember 24, 2024 | marketwatch.comInsulet Corp. stock underperforms Monday when compared to competitorsDecember 24, 2024 | marketwatch.comInsulet Corporation (NASDAQ:PODD) Delivered A Better ROE Than Its IndustryDecember 20, 2024 | finance.yahoo.comInsulet Co. (NASDAQ:PODD) Given Average Rating of "Moderate Buy" by BrokeragesShares of Insulet Co. (NASDAQ:PODD - Get Free Report) have received a consensus rating of "Moderate Buy" from the sixteen research firms that are presently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and thirteen have assigned aDecember 19, 2024 | marketbeat.comVirtu Financial LLC Makes New $616,000 Investment in Insulet Co. (NASDAQ:PODD)Virtu Financial LLC bought a new stake in shares of Insulet Co. (NASDAQ:PODD - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm bought 2,648 shares of the medical instruments supplier's stock, valued at approximatelDecember 15, 2024 | marketbeat.comToronto Dominion Bank Purchases 3,117 Shares of Insulet Co. (NASDAQ:PODD)Toronto Dominion Bank lifted its position in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 15.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 23,502 shares of the medical instruments supplier's stocDecember 15, 2024 | marketbeat.comGeode Capital Management LLC Increases Stake in Insulet Co. (NASDAQ:PODD)Geode Capital Management LLC grew its position in Insulet Co. (NASDAQ:PODD - Free Report) by 1.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,738,601 shares of the medical instrumenDecember 14, 2024 | marketbeat.comInsulet Co. (NASDAQ:PODD) Shares Sold by Y Intercept Hong Kong LtdY Intercept Hong Kong Ltd cut its stake in Insulet Co. (NASDAQ:PODD - Free Report) by 75.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,272 shares of the medical instruments supplier's stock after selling 12,943 shares during the period. Y IntDecember 13, 2024 | marketbeat.comOrion Portfolio Solutions LLC Purchases 3,623 Shares of Insulet Co. (NASDAQ:PODD)Orion Portfolio Solutions LLC grew its position in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 86.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,826 shares of the medical instruments suppliDecember 13, 2024 | marketbeat.comInsulet’s Strong International Performance and Optimistic Type 2 Diabetes Market Outlook Drive Positive Analyst RatingDecember 13, 2024 | markets.businessinsider.comJ.P. Morgan Keeps Their Buy Rating on Insulet (PODD)December 12, 2024 | markets.businessinsider.comInsulet Co. (NASDAQ:PODD) CAO Lauren Budden Sells 915 SharesDecember 12, 2024 | insidertrades.comNational Bank of Canada FI Cuts Stock Position in Insulet Co. (NASDAQ:PODD)National Bank of Canada FI lessened its stake in shares of Insulet Co. (NASDAQ:PODD - Free Report) by 42.0% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 28,468 shares of the medical instDecember 12, 2024 | marketbeat.comInsulet price target raised to $310 from $283 at CitiDecember 12, 2024 | markets.businessinsider.comWells Fargo Keeps Their Buy Rating on Insulet (PODD)December 12, 2024 | markets.businessinsider.comDecoding 11 Analyst Evaluations For InsuletDecember 11, 2024 | benzinga.comEdwards Lifesciences price target raised to $83 from $81 at CitiDecember 11, 2024 | markets.businessinsider.comInsulet (PODD) Receives a Buy from JefferiesDecember 11, 2024 | markets.businessinsider.comNomura Asset Management Co. Ltd. Has $35.71 Million Stock Holdings in Insulet Co. (NASDAQ:PODD)Nomura Asset Management Co. Ltd. raised its holdings in Insulet Co. (NASDAQ:PODD - Free Report) by 5.7% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 153,416 shares of the medical instruments supplier's stock after acquiring an additional 8,301December 10, 2024 | marketbeat.comQuantinno Capital Management LP Has $3.12 Million Holdings in Insulet Co. (NASDAQ:PODD)Quantinno Capital Management LP increased its holdings in Insulet Co. (NASDAQ:PODD - Free Report) by 118.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,416 shares of the medical iDecember 10, 2024 | marketbeat.com Get Insulet News Delivered to You Automatically Sign up to receive the latest news and ratings for PODD and its competitors with MarketBeat's FREE daily newsletter. Email Address PODD Media Mentions By Week PODD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PODD News Sentiment▼0.950.44▲Average Medical News Sentiment PODD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PODD Articles This Week▼119▲PODD Articles Average Week Get Insulet News Delivered to You Automatically Sign up to receive the latest news and ratings for PODD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Becton, Dickinson and Company News Edwards Lifesciences News IDEXX Laboratories News ResMed News DexCom News STERIS News Hologic News Baxter International News Globus Medical News Masimo News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PODD) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insulet Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Insulet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.